What is the true incidence of COVID-19 in patients with rheumatic diseases?

Ann Rheum Dis. 2021 Feb;80(2):e18. doi: 10.1136/annrheumdis-2020-217615. Epub 2020 Apr 22.
No abstract available

Keywords: arthritis; biological therapy; hydroxychloroquine.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Juvenile / drug therapy
  • Arthritis, Juvenile / epidemiology
  • Arthritis, Psoriatic / drug therapy
  • Arthritis, Psoriatic / epidemiology
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / epidemiology
  • COVID-19 / epidemiology*
  • Child
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Incidence
  • Italy / epidemiology
  • Janus Kinase Inhibitors / therapeutic use
  • Male
  • Middle Aged
  • Rheumatic Diseases / drug therapy
  • Rheumatic Diseases / epidemiology*
  • SARS-CoV-2
  • Severity of Illness Index
  • Spondylarthropathies / drug therapy
  • Spondylarthropathies / epidemiology
  • Tumor Necrosis Factor Inhibitors / therapeutic use

Substances

  • Antirheumatic Agents
  • Janus Kinase Inhibitors
  • Tumor Necrosis Factor Inhibitors